Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

Also called NCT01642134

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 124 participants (enrolled count) (from the registry)
Sponsor
Andres Iñiguez Romo, MD, PhD (from the registry)
Registry
  • NCT NCT01642134
  • EudraCT 2011-005784-24
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01642134. Randomized; single masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2019-06-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI
Acronym
AUREA
Condition
Aortic Valve Stenosis
Condition
Stroke
Intervention (Drug)
aspirin+clopidogrel (Duoplavin)
Lead sponsor
Andres Iñiguez Romo, MD, PhD (class: other government)

Record details

Record id
cardio:ct-nct01642134
Content hash
34265dff8876d480efdba06760e74e118072a9d47fc96e5d8312da0ed87a2383